INTELLIGENT BIO SOLUTIONS INC. (INBS)
Intelligent Bio Solutions Inc. operates as a life sciences firm focused on developing non-invasive, real-time monitoring and diagnostic solutions for both patients and their primary healthcare providers. A notable product in its portfolio is the Saliva Glucose Biosensor, an organic thin-film transistor designed to precisely measure glucose levels in saliva for effective diabetes management. Beyond this, the company is actively developing a SARS-CoV-2 Biosensor, intended to serve as a supplementary diagnostic tool to existing RNA virus detection methods. It also maintains a broad biosensor platform that encompasses diverse diagnostic modalities, including biochemistry, immunology, tumor marker identification, hormone analysis, and nucleic acid diagnostics. Incorporated in 2016 and based in New York, New York, the company was formerly known as GBS Inc. before adopting its current name in October 2022. Intelligent Bio Solutions Inc. operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
Intelligent Bio Solutions Inc.
Nasdaq bars a compliance period at 1:250
- 1:10Reverse splitDec 16, 202510 shares → 1
- 1:12Reverse splitJan 29, 202412 shares → 1
- 1:20Reverse splitFeb 10, 202320 shares → 1
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
| Revenue | $4.22M | $3.05M | $3.11M | $1.26M | $0 | $1.98M | $189K | $0 | $0 | $0 |
| YoY Growth | 38.1% | -1.9% | 147.6% | - | - | 949.3% | - | - | - | - |
| Cost of Revenue | $2.17M | $1.81M | $1.69M | $930K | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $2.05M | $1.25M | $1.43M | $327K | $0 | $1.98M | $189K | $0 | $0 | $0 |
| Gross Margin | 48.6% | 40.8% | 45.8% | 26.0% | - | 100.0% | 100.0% | - | - | - |
| Research and Development | $3.37M | $2.4M | $1.67M | $507K | $3.85M | $3.84M | $588K | $3.18M | $2.53M | $0 |
| Selling, General, and Administrative | $10.5M | $8.88M | $9.26M | $8.03M | $4.92M | $3.36M | $2.2M | $3.55M | $2.08M | $173K |
| Other | $785K | $611K | $776K | $4.39M | -$437K | $359K | $254K | $0 | $0 | $0 |
| Total Operating Expenses | $14.66M | $11.89M | $11.71M | $12.92M | $8.34M | $7.55M | $3.05M | $6.73M | $4.6M | $173K |
| Operating Income (EBIT) | -$12.61M | -$10.64M | -$10.28M | -$12.6M | -$8.34M | -$5.57M | -$2.86M | -$5.83M | -$4.6M | -$173K |
| Operating Margin | -299.1% | -348.7% | -330.5% | -1002.1% | - | -281.4% | -1513.7% | - | - | - |
| Interest Expense | $11K | $61K | $167K | $224K | $8K | $1.09M | $458K | $665K | $454K | $0 |
| Interest Income | $110K | $102K | $85K | $10K | $14K | $14K | $97 | $188 | $0 | $151K |
| Other Income (Expense) | $139K | $40K | $92K | $1.93M | $3K | -$1.49M | -$336K | -$1.56M | -$453K | -$139K |
| Income Before Tax (EBT) | -$12.47M | -$10.6M | -$10.19M | -$10.66M | -$8.33M | -$7.06M | -$3.19M | -$7.39M | -$5.06M | -$312K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$58K | -$36K | $0 |
| Net Income | -$12.43M | -$10.57M | -$10.16M | -$10.63M | -$8.31M | -$7.04M | -$3.16M | -$7.34M | -$5.02M | -$340K |
| Net Income Margin | -294.9% | -346.2% | -326.4% | -845.9% | - | -355.3% | -1676.2% | - | - | - |
| Supplementary Data | ||||||||||
| EPS | -8.44 | -20.00 | -63.80 | -105.80 | -113.30 | -162.20 | -89.20 | -210.10 | -146.00 | -9.90 |
| Diluted EPS | -8.44 | -20.00 | -63.80 | -105.80 | -113.30 | -162.20 | -89.20 | -210.10 | -146.00 | -9.90 |
| Weighted Average OS | 1.47M | 527,364 | 318,500 | 200,900 | 73,326 | 52,074 | 70,920 | 60,396 | 60,396 | 60,396 |
| EBITDA | -$11.29M | -$9.21M | -$8.81M | -$9.47M | -$8.33M | $0 | $0 | -$896K | $467 | $16K |
| EBITDA Margin | -267.9% | -301.7% | -283.1% | -753.8% | - | - | - | - | - | - |
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
| Assets | ||||||||||
| Current Assets | ||||||||||
| Cash and Cash Equivalents | $3.99M | $1.02M | $6.3M | $1.54M | $8.24M | $12.57M | $427K | $198K | $418K | $56K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $47K | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $3.99M | $1.02M | $6.3M | $1.54M | $8.28M | $12.57M | $427K | $198K | $418K | $56K |
| Accounts Receivable | $848K | $1.6M | $978K | $833K | $1.53M | $2.1M | $20K | $95K | $36K | $0 |
| Inventory | $419K | $635K | $778K | $980K | $0 | $0 | $0 | $1.98M | $2.03M | $0 |
| Other Current Assets | $1.84M | $395K | $111K | $34K | $937K | $3.21M | $0 | $0 | $2M | $611K |
| Total Current Assets | $7.1M | $4.14M | $8.53M | $3.86M | $10.87M | $18.21M | $476K | $2.33M | $2.5M | $667K |
| Long-Term Assets | ||||||||||
| Property, Plant & Equipment Net | $2.05M | $321K | $873K | $1.24M | $391K | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $2.8M | $3.79M | $4.37M | $5.26M | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $136K | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $0 | $1.09M | $3.65M | $1.86M | $1.98M | $1.98M | $611K |
| Total Long-Term Assets | $4.84M | $4.11M | $5.24M | $6.49M | $1.48M | $3.65M | $2M | $1.98M | $1.98M | $611K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$1.98M | -$1.98M | -$611K |
| Total Assets | $11.94M | $8.25M | $13.78M | $10.35M | $12.35M | $21.86M | $2.48M | $2.33M | $2.5M | $667K |
| Liabilities | ||||||||||
| Current Liabilities | ||||||||||
| Accounts Payable | $712K | $897K | $602K | $1.2M | $716K | $1.36M | $484K | $850K | $167K | $339K |
| Short-Term Debt | $147K | $197K | $790K | $577K | $0 | $0 | $5.13M | $5.13M | $4.84M | $3.53M |
| Current Income Tax Payable | $0 | $85K | $50K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $2.17M | $2.49M | $2.34M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $4.07M | $535K | $332K | $1.19M | $2.84M | $2.1M | $1.83M | $50K | $466K | $2.71M |
| Total Current Liabilities | $4.93M | $5.35M | $5.45M | $5.88M | $4.66M | $3.68M | $7.69M | $6.31M | $5.56M | $6.58M |
| Long-Term Liabilities | ||||||||||
| Long-Term Debt | $1.67M | $0 | $0 | $759K | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $50K | $85K | $64K | -$331K | $1.14M | $3.17M | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $1.72M | $85K | $145K | $784K | $1.14M | $3.17M | $0 | $0 | $5.01M | $3.87M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$5.01M | -$3.87M |
| Total Liabilities | $6.65M | $5.44M | $5.6M | $6.67M | $5.81M | $6.85M | $7.69M | $6.31M | $5.56M | $6.58M |
| Stockholders' Equity | ||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $13K | $24K | $15.03M | $8.72M | $0 |
| Common Stock | $29K | $73K | $35K | $23K | $7K | $136K | $86K | $1.95M | $0 | $0 |
| Retained Earnings | -$74.96M | -$62.53M | -$51.96M | -$41.81M | -$31.18M | -$22.87M | -$15.83M | -$12.67M | -$5.33M | -$312K |
| Comprehensive Income & Other | -$546K | -$328K | -$713K | -$575K | -$788K | -$661K | -$364K | -$217K | $571K | $3K |
| Other Stockholders' Equity | $80.45M | $65.46M | $60.26M | $45.58M | $37.79M | $37.79M | $10.56M | $6.1M | $957K | -$5.6M |
| Total Equity | $5.51M | $3M | $8.33M | $3.8M | $6.62M | $15.06M | -$5.19M | -$4.62M | -$4.38M | -$5.91M |
| Minority Interest | -$220K | -$182K | -$146K | -$112K | -$79K | -$51K | -$28K | $638K | $1.31M | $0 |
| Total Liabilities and Equity | $12.16M | $8.43M | $13.93M | $10.47M | $12.43M | $21.91M | $2.5M | $1.69M | $1.18M | $667K |
| Supplementary Data | ||||||||||
| Total Debt | $1.82M | $282K | $1.15M | $1.92M | $0 | $0 | $5.13M | $5.13M | $4.84M | $3.53M |
| Net Debt | -$2.17M | -$738K | -$5.16M | $378K | -$8.24M | -$12.57M | $4.71M | $4.93M | $4.42M | $3.48M |
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
| Operating Activities | ||||||||||
| Net Income | -$12.47M | -$10.6M | -$10.19M | -$10.66M | -$8.33M | -$7.06M | -$3.19M | -$7.39M | -$5.06M | -$312K |
| Depreciation & Amortization | $1.16M | $1.21M | $1.21M | $967K | $0 | $5.21M | $2.6M | $5.83M | $4.6M | $189K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $195K | $238K | $230K | $260K | $0 | $0 | $0 | $1.95M | $0 | $0 |
| Changes in Working Capital: | ||||||||||
| Accounts Receivable | -$326K | -$2.86M | -$14K | $592K | $2.5M | -$1.03M | $118K | $0 | $0 | $0 |
| Inventory | $217K | $142K | $202K | -$345K | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$685K | $0 | -$633K | $85K | $243K | -$973K | $2.41M | -$133K | -$328K | $65K |
| Other Working Capital | -$431K | $2M | -$258K | -$252K | -$305K | -$2.94M | $99K | -$133K | -$328K | $0 |
| Total Working Capital Change | -$1.23M | -$721K | -$702K | $79K | $2.44M | -$4.94M | $2.63M | -$133K | -$328K | $65K |
| Other Non-Cash Items | $408K | $197K | -$122K | $1.98M | $2.54M | -$4.51M | -$2.54M | -$5.83M | -$4.6M | -$186K |
| Net Cash from Operating | -$11.93M | -$9.68M | -$9.57M | -$7.38M | -$3.36M | -$11.3M | -$499K | -$5.58M | -$5.38M | -$244K |
| Investing Activities | ||||||||||
| Capital Expenditures | -$126K | -$232K | -$221K | -$505K | -$380K | $0 | $0 | $0 | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | -$189K | $0 | $0 | -$14K | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | -$500K | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $40K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$86K | -$232K | -$221K | -$694K | -$880K | $0 | -$14K | $0 | $0 | $0 |
| Financing Activities | ||||||||||
| Debt Repaid | - | - | - | - | - | - | - | - | - | -$3.85M |
| Common Stock Issuance | $14.98M | $4.59M | $12.9M | $2.55M | $0 | $21.6M | $0 | $5.32M | $8.02M | -$169K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $8K | $1.66M | -$1.34M | $0 | -$1.49M | -$116K | $5.32M | $3.75M | -$3.38M |
| Net Cash from Financing | $14.98M | $4.6M | $14.56M | $1.44M | $0 | $23.4M | $734K | $5.32M | $5.18M | $300K |
| Forex Effect | $1K | $27K | -$707 | -$65K | -$97K | $40K | $8K | $38K | $568K | $3K |
| Net Change in Cash | $2.97M | -$5.28M | $4.77M | -$6.7M | -$4.34M | $12.15M | $229K | -$220K | $362K | $59K |
| Supplementary Data | ||||||||||
| Operating Cash Flow | -$11.93M | -$9.68M | -$9.57M | -$7.38M | -$3.36M | -$11.3M | -$499K | -$5.58M | -$5.38M | -$244K |
| Capital Expenditure | -$126K | -$232K | -$221K | -$505K | -$380K | -$3 | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$12.05M | -$9.91M | -$9.79M | -$7.88M | -$3.74M | -$11.3M | -$499K | -$5.58M | -$5.38M | -$244K |
| Cash at Beginning | $1.02M | $6.3M | $1.54M | $8.24M | $12.57M | $427K | $198K | $418K | $56K | -$3K |
| Cash at End | $3.99M | $1.02M | $6.3M | $1.54M | $8.24M | $12.57M | $427K | $198K | $418K | $56K |